Welcome to the Acessa™ Physician Training Portal
Both patients and physicians want a solution that is minimally invasive, allows for rapid recovery, has a low rate of recurrence, and eliminates the need for a hysterectomy. With the Acessa System, both the surgeon and the patient are able to achieve their goals. Using a laparoscopic, outpatient procedure, the physician can provide a treatment that is low risk to the patient and is highly successful at treating all of the patient’s existing fibroids. By treating all of the fibroids, the risk of the symptom recurrence is low. Patient’s generally take mild anti-inflammatories following the procedure which allows them to return to work in 4-5 days.
Founded in 2004, Halt Medical is a medical device company focused on establishing a new standard of care for women with symptomatic uterine fibroids. The Company has developed and launched the Acessa System and Procedure, using radiofrequency energy to destroy uterine fibroids. The results of both U.S. and international trials have led to the clearance of the product by the FDA for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. The Acessa System also has regulatory approval to treat symptomatic uterine fibroids in the European Union, Canada, and Mexico. The Company is located in Brentwood, CA.